Neuburgh Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Neuburgh Advisers’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$52.2M	Sell	179,278 -1,188	-0.7%	-$340K	1.62%	14
2019 Q2	$53M	Sell	180,466 -5,522	-3%	-$1.52M	1.71%	12
2019 Q1	$50.9M	Buy	185,988 +7,502	+4%	+$1.87M	1.73%	11
2018 Q4	$39.9M	Buy	178,486 +528	+0.3%	+$124K	1.57%	11
2018 Q3	$43.4M	Sell	177,958 -10,714	-6%	-$2.46M	1.4%	14
2018 Q2	$39.1M	Sell	188,672 -5,324	-3%	-$1.13M	1.3%	17
2018 Q1	$40.1M	Sell	193,996 -396	-0.2%	-$83.1K	1.4%	16
2017 Q4	$36.9M	Buy	194,392 +3,520	+2%	+$674K	1.32%	16
2017 Q3	$36.1M	Sell	190,872 -20,702	-10%	-$3.75M	1.34%	16
2017 Q2	$36.9M	Sell	211,574 -7,392	-3%	-$1.24M	1.4%	15
2017 Q1	$33.6M	Sell	218,966 -8,734	-4%	-$1.33M	1.33%	17
2016 Q4	$32.1M	Buy	+227,700	New	+$33.6M	1.45%	15

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Neuburgh Advisers's TMO Position: Q3 2019 in Review

Neuburgh Advisers reduced its Thermo Fisher Scientific (TMO) stake by 0.66% in Q3 2019, selling an estimated $340K and leaving 179,278 shares worth $52.2M. The position accounts for 1.62% of the portfolio, ranked #14.

Neuburgh Advisers first reported a position in TMO in Q4 2016 and has held it in 12 quarters since. The position peaked at $53M in Q2 2019. 1,543 funds tracked by Wall St. Rank hold TMO as of Q3 2019.

Neuburgh Advisers held 179,278 shares of Thermo Fisher Scientific worth $52.2M as of Q3 2019.
Neuburgh Advisers sold 1,188 Thermo Fisher Scientific shares in Q3 2019, an estimated $340K.
Thermo Fisher Scientific made up 1.62% of Neuburgh Advisers's portfolio in Q3 2019, its #14 holding.
Neuburgh Advisers first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 12 quarters since.
Neuburgh Advisers's Thermo Fisher Scientific position peaked at $53M in Q2 2019.
1,543 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.